We are live on ! Find out more
TELA icon

TELA Bio
TELA

30 hedge funds and large institutions have $130M invested in TELA Bio in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 9

4.08% more ownership

Funds ownership: 72.63% → 76.71% (+4.1%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

4% less capital invested

Capital invested by funds: $135M → $130M (-$5.01M)

17% less funds holding

Funds holding: 36 → 30 (-6)

75% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 8

Holders
30
Holders Change
-6
Holders Change %
-16.67%
% of All Funds
0.47%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
2
Increased
11
Reduced
9
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
EWM
Essex Woodlands Management
Texas
+$17.1M
2
VCIM
Velan Capital Investment Management
Georgia
+$1.83M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$528K
4
WP
WMS Partners
Maryland
+$341K
5
OM
Opaleye Management
Massachusetts
+$328K

Top Sellers

Rank Fund Capital Flow
1
CAC
Cowen and Company
New York
-$5.55M
2
RI
RTW Investments
New York
-$4.63M
3
AC
Armistice Capital
New York
-$1.89M
4
Goldman Sachs
Goldman Sachs
New York
-$252K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$152K
Name Holding Trade Value Shares
Change 		Change in
Stake
EWM
1
Essex Woodlands Management
Texas
$38.6M +$17.1M +1,410,008 +74%
O
2
OrbiMed
New York
$35.2M – – –
RI
3
RTW Investments
New York
$11.8M -$4.63M -382,140 -27%
PVI
4
Pura Vida Investments
New York
$6.6M +$39.9K +3,300 +0.6%
OM
5
Opaleye Management
Massachusetts
$5.55M +$328K +27,133 +6%
VCIM
6
Velan Capital Investment Management
Georgia
$5.25M +$1.83M +151,400 +50%
SAM
7
Silvercrest Asset Management
New York
$4.61M +$43.7K +3,610 +0.9%
Vanguard Group
8
Vanguard Group
Pennsylvania
$4.55M +$528K +43,633 +13%
PCM
9
Pentwater Capital Management
Florida
$3.63M – – –
GPCM
10
Granite Point Capital Management
Massachusetts
$2.65M – – –
AC
11
Armistice Capital
New York
$2.23M -$1.89M -156,000 -45%
SSA
12
Schonfeld Strategic Advisors
New York
$1.69M +$19.4K +1,600 +1%
JAMONY
13
Jacob Asset Management of New York
California
$1.5M -$48.5K -4,006 -3%
PHP
14
Parkman Healthcare Partners
Connecticut
$1.26M +$51.1K +4,222 +4%
SMH
15
Sanders Morris Harris
Texas
$1.22M -$24.2K -2,000 -2%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$755K -$12 -1 -0%
BCM
17
Bridgeway Capital Management
Texas
$721K – – –
PNC Financial Services Group
18
PNC Financial Services Group
Pennsylvania
$549K – – –
WP
19
WMS Partners
Maryland
$327K +$341K +28,150 New
State Street
20
State Street
Massachusetts
$303K +$26.2K +2,167 +9%
BlackRock
21
BlackRock
New York
$249K -$11.7K -969 -4%
Susquehanna International Group
22
Susquehanna International Group
Pennsylvania
$190K -$42K -3,471 -17%
Northern Trust
23
Northern Trust
Illinois
$173K – – –
Two Sigma Investments
24
Two Sigma Investments
New York
$123K -$66.6K -5,500 -34%
TRCT
25
Tower Research Capital (TRC)
New York
$14K +$8.2K +677 +132%
1
2

TELA Hedge Fund Activity: Q1 2022 in Review

30 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in TELA Bio (TELA) for Q1 2022, worth a combined $130M — down 3.7% from $135M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of TELA and 2 opened new positions — a net loss of 6 holders — while 9 trimmed existing stakes and 11 added.

The largest buyer was Essex Woodlands Management, adding an estimated $17.1M. The largest seller was Cowen and Company, exiting entirely with an estimated $5.55M sold.

  • 30 institutional investors held TELA Bio (TELA) as of Q1 2022, down from 36 in Q4 2021.
  • Funds reported $130M of TELA Bio stock for Q1 2022, down 3.7% quarter-over-quarter.
  • 2 funds opened new TELA Bio positions in Q1 2022 and 8 closed out, a net change of -6 holders.
  • The largest TELA Bio buyer in Q1 2022 was Essex Woodlands Management, an estimated $17.1M added.
  • The largest TELA Bio seller in Q1 2022 was Cowen and Company, an estimated $5.55M sold.

Based on aggregated 13F filings for Q1 2022.